View Older Stories View More Recent Stories
-
Form 497 LAZARD FUNDS INC
-
Dennis K. Berman Joins Lazard as a Managing Director, Financial Advisory
-
Sanofi (SNY) Commences Tender Offer for Acquisition of Bioverativ (BIVV)
-
Sanofi Commences Tender Offer for Acquisition of Bioverativ Inc.
-
Sanofi Commences Tender Offer for Acquisition of Bioverativ Inc.
-
Sanofi Commences Tender Offer for Acquisition of Bioverativ Inc.
-
Form SC 13G/A ASA Gold & Precious Meta Filed by: LAZARD ASSET MANAGEMENT LLC
-
Form SC 13G/A ABERDEEN EMERGING MARKET Filed by: LAZARD ASSET MANAGEMENT LLC
-
Form SC 13G/A ABERDEEN LATIN AMERICA Filed by: LAZARD ASSET MANAGEMENT LLC
-
Form SC 13G/A ABERDEEN JAPAN EQUITY Filed by: LAZARD ASSET MANAGEMENT LLC
-
Investors Bank Launches Equipment Finance Group
-
BlackArch Partners Announces Hiring of Cael Pulitzer
-
Lazard Asset Management Hires International Equity Value Team
-
Lazard (LAZ) PT Raised to $67 at Nomura/Instinet
-
Lazard (LAZ) PT Raised to $65 at JMP Securities
-
Western banks make push into Japanese dealmaking as fee pool hits record
-
Form SC 13G Lazard World Dividend & Filed by: SIT INVESTMENT ASSOCIATES INC
-
Form 8-K Lazard Ltd For: Feb 01
-
Lazard Ltd. (LAZ) Tops Q4 EPS by 22c, Beats on Revenues
-
Lazard Ltd Reports Full-Year and Fourth-Quarter 2017 Results
-
Lazard Ltd. (LAZ) Declares $1.30 Special Dividend; 2.2% Yield
-
Lazard Ltd. (LAZ) Declares $0.41 Quarterly Dividend; 2.8% Yield
-
Lazard Declares Dividends of $1.71 Per Share
-
Royce Global Value Trust (NYSE: RGT) as of December 31, 2017
-
Form SC 13G/A Lazard World Dividend & Filed by: FIRST TRUST PORTFOLIOS LP
-
Nomura hires 15 senior bankers in its Investment Banking business in the Americas
-
WestRock (WRK) to Acquire KapStone (KS) for $35 per Share
-
WestRock Signs Definitive Agreement to Acquire KapStone for $35 per Share
-
Sanofi (SNY) to Acquire Ablynx (ABLX) for $4.85B, Topping Novo Nordisk (NVO) Bid
-
Sanofi beats Novo to buy Ablynx for $4.8 billion in biotech M&A boom
-
Sanofi to acquire Ablynx for €3.9 Billion
-
Sanofi to acquire Ablynx for €3.9 Billion
-
SANOFI TO ACQUIRE ABLYNX FOR €3.9 BILLION
-
SANOFI TO ACQUIRE ABLYNX FOR €3.9 BILLION
-
Sanofi to acquire Ablynx for €3.9 Billion
-
Form 485APOS LAZARD RETIREMENT SERIES
-
Exclusive: U.S. gunmaker Remington turns to debt restructuring advisors - sources
-
Form 497K LAZARD FUNDS INC
-
Form 497 LAZARD FUNDS INC
-
Summit Partners Announces Promotions
-
ENGIE Enters into the Capital of EPS: an Industrial Partner to Scale up Globally
-
Form SC 13G/A LAZARD GLOBAL TOTAL RETU Filed by: FIRST TRUST PORTFOLIOS LP
-
Claire's Stores, Inc. Retains Lazard to Evaluate Capital Structure Solution
-
Biotech M&A takes off as Sanofi and Celgene spend $20 billion
-
Sanofi digs deep to buy U.S. hemophilia group Bioverativ for $11.6 billion
-
Sanofi (SNY) to Acquire Bioverativ (BIVV) for $11.6B
-
Sanofi digs deep to buy U.S. haemophilia group Bioverativ for $11.6 billion
-
Sanofi to Acquire Bioverativ for $11.6 Billion
-
Sanofi to Acquire Bioverativ for $11.6 Billion
-
Sanofi to Acquire Bioverativ for $11.6 Billion

